Clinical Trials
3 trialsNCT04619004 2026-05-14
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
Daiichi Sankyo
Phase 2 Active not recruiting
NCT03260491 2026-03-05
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
Daiichi Sankyo
Phase 1 Active not recruiting
NCT04676477 2025-06-22
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
Daiichi Sankyo
Phase 1 Active not recruiting